Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ecnoglutide

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Hangzhou Sciwind Biosciences Co · Phase 3 · Completed · Enrollment 664

NCT05813795

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
C1- XW003 Low Dosagen/rn/rn/rn/r
C1-Placebon/rn/rn/rn/r
C2- XW003 Medium Dosagen/rn/rn/rn/r
C2-Placebon/rn/rn/rn/r
C3- XW003 High Dosagen/rn/rn/rn/r
C3-Placebon/rn/rn/rn/r

Not shown

  • C1- XW003 Low Dosage: endpoint not reported
  • C1-Placebo: endpoint not reported
  • C2- XW003 Medium Dosage: endpoint not reported
  • C2-Placebo: endpoint not reported
  • C3- XW003 High Dosage: endpoint not reported
  • C3-Placebo: endpoint not reported